Phibro Net Income From Continuing Ops from 2010 to 2026
| PAHC Stock | USD 52.26 0.99 1.93% |
Net Income From Continuing Ops | First Reported 2000-09-30 | Previous Quarter 26.5 M | Current Value 27.5 M | Quarterly Volatility 8.4 M |
Check Phibro Animal financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Phibro Animal's main balance sheet or income statement drivers, such as Depreciation And Amortization of 55.1 M, Interest Expense of 18.4 M or Selling General Administrative of 349.5 M, as well as many indicators such as Price To Sales Ratio of 0.87, Dividend Yield of 0.0272 or PTB Ratio of 3.19. Phibro financial statements analysis is a perfect complement when working with Phibro Animal Valuation or Volatility modules.
Phibro | Net Income From Continuing Ops | Build AI portfolio with Phibro Stock |
Analyzing Phibro Animal's Net Income From Continuing Ops over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income From Continuing Ops has evolved provides context for assessing Phibro Animal's current valuation and future prospects.
Latest Phibro Animal's Net Income From Continuing Ops Growth Pattern
Below is the plot of the Net Income From Continuing Ops of Phibro Animal Health over the last few years. It is Phibro Animal's Net Income From Continuing Ops historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Phibro Animal's overall financial position and show how it may be relating to other accounts over time.
| Net Income From Continuing Ops | 10 Years Trend |
|
Net Income From Continuing Ops |
| Timeline |
Phibro Net Income From Continuing Ops Regression Statistics
| Arithmetic Mean | 36,167,408 | |
| Geometric Mean | 21,846,868 | |
| Coefficient Of Variation | 78.09 | |
| Mean Deviation | 23,188,924 | |
| Median | 43,437,600 | |
| Standard Deviation | 28,242,541 | |
| Sample Variance | 797.6T | |
| Range | 85.9M | |
| R-Value | 0.31 | |
| Mean Square Error | 767.5T | |
| R-Squared | 0.1 | |
| Significance | 0.22 | |
| Slope | 1,750,681 | |
| Total Sum of Squares | 12762.3T |
Phibro Net Income From Continuing Ops History
About Phibro Animal Financial Statements
Phibro Animal stakeholders use historical fundamental indicators, such as Phibro Animal's Net Income From Continuing Ops, to determine how well the company is positioned to perform in the future. Although Phibro Animal investors may analyze each financial statement separately, they are all interrelated. For example, changes in Phibro Animal's assets and liabilities are reflected in the revenues and expenses on Phibro Animal's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Phibro Animal Health. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Income From Continuing Ops | 43.4 M | 36.3 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Phibro Animal Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Phibro Animal's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Phibro Animal Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Phibro Animal Health Stock:Check out the analysis of Phibro Animal Correlation against competitors. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Will Pharmaceuticals sector continue expanding? Could Phibro diversify its offerings? Factors like these will boost the valuation of Phibro Animal. Anticipated expansion of Phibro directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Phibro Animal data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 7.52 | Dividend Share 0.48 | Earnings Share 2.26 | Revenue Per Share | Quarterly Revenue Growth 0.209 |
The market value of Phibro Animal Health is measured differently than its book value, which is the value of Phibro that is recorded on the company's balance sheet. Investors also form their own opinion of Phibro Animal's value that differs from its market value or its book value, called intrinsic value, which is Phibro Animal's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Phibro Animal's market value can be influenced by many factors that don't directly affect Phibro Animal's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Phibro Animal's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Phibro Animal should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Phibro Animal's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.